Xbrane appoints Martin Åmark as new CEO
Stockholm, Sweden – 2015-08-27 – Xbrane, a commercial phase Biopharmaceutical company specialized in High Demand Complex Generics, announces the appointment of Martin Åmark as the new Chief Executive Officer. He will lead the company together with Chief Operating Officer and former CEO Siavash Bashiri who will focus on the development and commercialisation of novel biosimilars.
“Martins’s appointment as the new CEO is an important step in our effort to create a strong and multifaceted management team, said Saeid Esmaeilzadeh, Chairman of Xbrane. “Having spent nearly a decade working alongside senior management teams with M&A, finance, operational and organisational strategies across multiple industries, including life science and pharmaceuticals, we believe Martin’s expertise make him the ideal fit for the role as CEO. We are excited to have Martin on board.”
Martin Åmark holds a MSc in industrial engineering and management from Linköping Institute of Technology and a MBA from INSEAD. Martin joins from Bain & Co where he worked for more than 8 years.
“It’s an exciting time to be joining Xbrane, with the company entering a global market bringing affordable novel High Demand Complex Generics to underserved people” said Martin Åmark. “I´m highly impressed with Xbrane’s technology and look forward to work with the team to introduce therapies for patients in need.
About Xbrane Biopharmaceuticals
Xbrane is a commercial phase Swedish Biopharmaceutical Company specialized in High Demand Complex Generics. Xbrane has world leading expertise in developing biogenerics for injectable slow release drugs and proprietary high-yield protein expression technology for the development of biosimilars. The goal is to become a global leader within the company’s portfolio of High Demand Complex Generics.
Xbranes’s headquarters is located in Stockholm and the company’s in-house research and development facilities are in Sweden and Italy.
For further information, please contact:
Martin Åmark, CEO, Xbrane
M: +46 (0) 763-093 777
Siavash Bashiri, COO, Xbrane
M: +46 (0) 734-343 619